Vance Berger
About Vance Berger
Vance Berger is a biostatistician with extensive academic and professional experience, including a PhD from Rutgers University and current work at the NIH since 1999. He specializes in clinical trial methodology and engages in various hobbies, including chess, healthy cooking, and soccer.
Work at National Institutes of Health
Vance Berger has served as a Biostatistician at the National Institutes of Health (NIH) since 1999. His role involves applying statistical methods to health-related research, contributing to the design and analysis of clinical trials. Berger focuses on the relationships among randomization methods, allocation concealment, and selection bias, which are critical elements in ensuring the integrity of clinical research. His extensive experience at NIH spans over 25 years, during which he has been involved in various research initiatives aimed at improving methodological rigor in randomized clinical trials.
Education and Expertise
Vance Berger holds a Doctor of Philosophy (PhD) in Statistics from Rutgers University, where he studied from 1990 to 1995. Prior to that, he earned a Master of Science (MS) in Statistics from Stanford University, completing his studies from 1987 to 1989. His academic background also includes a Bachelor's Degree in Biometry/Biometrics from Cornell University, obtained from 1983 to 1987. This strong educational foundation equips him with the expertise necessary for his role as a biostatistician, particularly in the context of clinical trials.
Previous Experience at FDA and Pfizer
Before joining the National Institutes of Health, Vance Berger worked as a Biostatistician at the Food and Drug Administration (FDA) from 1995 to 1999. His experience at FDA involved statistical analysis related to drug approval processes and public health. Additionally, he interned at Pfizer from 1987 to 1988, where he gained practical experience in the pharmaceutical industry. These roles contributed to his development as a biostatistician and provided him with insights into regulatory and industry standards.
Research Interests and Collaborations
Vance Berger is open to research collaborations that focus on the methodological rigor of randomized clinical trials. His research interests include exploring the relationships among randomization methods, allocation concealment, and selection bias. By engaging in collaborative efforts, he aims to enhance the quality and reliability of clinical research outcomes. His commitment to advancing statistical methodologies reflects his dedication to improving health research practices.
Personal Interests and Hobbies
In addition to his professional work, Vance Berger has several personal interests. He enjoys collecting coins as a hobby and is passionate about chess and other strategy games. He also emphasizes healthy cooking and eating in his lifestyle. Furthermore, Berger actively runs adult co-ed soccer teams in Washington, D.C., and Maryland, where he plays a role in recruiting players, particularly women, to participate in the sport.